Vinbarbital
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number |
|
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.004.309 |
Chemical and physical data | |
Formula | C11H16N2O3 |
Molar mass | 224.260 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
NY (what is this?) (verify) |
Vinbarbital is a hypnotic drug which is a barbiturate derivative.[1] It was developed by Sharp and Dohme in 1939.[2]
References
- ↑ Mueller VA (March 1950). "An analysis and evaluation of vinbarbital sodium for obstetric amnesia and analgesia". American Journal of Obstetrics and Gynecology. 59 (3): 679–84. doi:10.1016/0002-9378(50)90253-5. PMID 15405833.
- ↑ US 2187703
Alcohols |
|
---|---|
Barbiturates |
|
Benzodiazepines |
|
Carbamates | |
Flavonoids |
|
Imidazoles | |
Kava constituents |
|
Monoureides |
|
Neuroactive steroids |
|
Nonbenzodiazepines | |
Phenols | |
Piperidinediones | |
Pyrazolopyridines | |
Quinazolinones | |
Volatiles/gases |
|
Others/unsorted |
|
See also: Receptor/signaling modulators • GABA receptor modulators • GABA metabolism/transport modulators |
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.